President Donald Trump has been successful in convincing many of the world’s top drugmakers to commit to manufacturing more of their prescription treatments in the U.S. But what about the onshoring of ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...
The NTT INDYCAR SERIES recognizes entrant, driver and manufacturer champions. To facilitate competition for these championships, INDYCAR calculates and publicizes complete rankings of all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback